These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
570 related articles for article (PubMed ID: 9508381)
21. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma]. Keijzer R; Bril H; van der Loo EM; de Graaf PW Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391 [TBL] [Abstract][Full Text] [Related]
23. Preliminary experiences of intralesional immunotherapy in cutaneous metastatic melanoma. Ridolfi L; Ridolfi R Hepatogastroenterology; 2002; 49(44):335-9. PubMed ID: 11995445 [TBL] [Abstract][Full Text] [Related]
24. [Melanoma]. Saida T Gan To Kagaku Ryoho; 2006 Oct; 33(10):1386-91. PubMed ID: 17033225 [TBL] [Abstract][Full Text] [Related]
25. Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses. Wei Y; Sticca RP; Holmes LM; Burgin KE; Li J; Williamson J; Evans L; Smith SJ; Stephenson JJ; Wagner TE Int J Oncol; 2006 Mar; 28(3):585-93. PubMed ID: 16465362 [TBL] [Abstract][Full Text] [Related]
26. [Cellular immune function influence on postoperative patients with hepatocellular carcinoma and the clinical effect of TILs treatment]. Ba M; He S; Zhang C; Wei D; Zhao Z Zhonghua Wai Ke Za Zhi; 1999 Jan; 37(1):5-7. PubMed ID: 11829765 [TBL] [Abstract][Full Text] [Related]
27. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma. Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334 [TBL] [Abstract][Full Text] [Related]
28. [Adjuvant adoptive immunotherapy in patients with stage III and resected stage IV melanoma: a pilot study]. Verdecchia GM; Ridolfi L; Ridolfi R; Riccobon A; Bertagni A; Vagliasindi A; Petrini M; Stefanelli M; Milandri C; Amadori D Tumori; 2003; 89(4 Suppl):298-300. PubMed ID: 12903626 [TBL] [Abstract][Full Text] [Related]
29. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database. Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103 [TBL] [Abstract][Full Text] [Related]
30. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Bellati F; Angioli R; Manci N; Angelo Zullo M; Muzii L; Plotti F; Basile S; Panici PB Gynecol Oncol; 2005 Jan; 96(1):227-31. PubMed ID: 15589606 [TBL] [Abstract][Full Text] [Related]
31. Melanoma of the ear: prognostic factors and surgical strategies. Jahn V; Breuninger H; Garbe C; Moehrle M Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802 [TBL] [Abstract][Full Text] [Related]
32. [Regional lymph nodes at a distance]. Kroon BB; Hoefnagel CA; Valdés Olmos RA; Nieweg OE Ned Tijdschr Geneeskd; 2008 Sep; 152(37):1997-2000. PubMed ID: 18825884 [TBL] [Abstract][Full Text] [Related]
33. Desmoplastic and neurotropic melanoma. Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878 [TBL] [Abstract][Full Text] [Related]
34. A pilot study of intraperitoneal recombinant interleukin-2 and ex vivo activated intracavitary lymphocytes in patients with malignant peritoneal spread: I. Clinical aspects. Lurie H; Rakovsky E; Fenig E; Davidovitz J; Adler A Mol Biother; 1989; 1(3):163-9. PubMed ID: 2604915 [TBL] [Abstract][Full Text] [Related]
35. Cascading adoptive cell therapy for metastatic melanoma. Su X; Zhang L; Wu S; Jin L; Ye J; Guan Z; Chen R Cancer Biother Radiopharm; 2011 Jun; 26(3):401-6. PubMed ID: 21711116 [TBL] [Abstract][Full Text] [Related]
36. Intratumoral adoptive immunotherapy with tumor infiltrating lymphocytes (TIL) in a melanoma patient leading to regression of local tumor mass. A case report. Möller P; Wittig B; Schadendorf D Anticancer Res; 1998; 18(2B):1237-41. PubMed ID: 9615794 [TBL] [Abstract][Full Text] [Related]
37. [Sentinel node biopsy in cutaneous malignant melanoma of the lower extremities]. Kjaer BK; Knudsen MA; Dahlstrøm KK Ugeskr Laeger; 1999 Apr; 161(16):2358-61. PubMed ID: 10235040 [TBL] [Abstract][Full Text] [Related]
38. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients. Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596 [TBL] [Abstract][Full Text] [Related]
39. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633 [TBL] [Abstract][Full Text] [Related]